CB1 |
Ki = 3.3~4.9 microM |
Inverse agonist/antagonist |
(Tham et al., 2019; Thomas et al., 2007) |
|
IC50 = 0.27-0.96 microM |
Negative allosteric modulators |
(Laprairie
et al., 2015) |
CB2 |
Ki = 4.3 μM |
Antagonist |
(Martínez-Pinilla et al.,
2017) |
|
EC50 = 503 nM |
Inverse agonist |
(Thomas et al.,
2007) |
|
IC50 = 3 nM |
Negative allosteric modulators |
(Martínez-Pinilla et al., 2017) |
GPR55 |
IC50 = 445 nM |
Antagonist |
(Ryberg et al.,
2007) |
TPPA1 |
EC50 = 110 nM |
Agonist |
(Luciano De
Petrocellis et al., 2011) |
TRPV1 |
EC50 = 1000 nM |
Agonist |
(Bisogno et al.,
2001; Luciano De Petrocellis et al., 2011) |
TRPV2 |
EC50 = 1250 nM |
Agonist |
(Luciano De
Petrocellis et al., 2011) |
TRPV3 |
EC50 = 3700 nM |
Agonist |
(L. De Petrocellis et
al., 2012) |
TRPV4 |
EC50 = 800 nM |
Agonist |
(L. De Petrocellis et
al., 2012) |
TRPM8 |
IC50 = 160 nM |
Antagonist |
(Luciano De
Petrocellis et al., 2008) |
5-HT1A
|
N.D |
Indirect agonist |
(Ethan B. Russo et
al., 2005) |
PPARγ |
EC50 = 2010 nM |
Agonist |
(Granja et al.,
2012) |
FAAH |
27.5 μM |
Inhibitor |
(Bisogno et al., 2001; Elmes et al.,
2015) |
D2
|
Ki= 11 nM at D2High
Ki = 2800 nm at D2Low
|
Partial agonist
|
(Ryberg et al., 2007)
|